As widely predicted, the plaintiff’s bar has turned its attention to the burgeoning CBD category with a series of lawsuits alleging that products contain “significantly lower levels of CBD than advertised.”
The United Natural Products Alliance has signed a Memorandum of Understanding (MOU) with the University of Arkansas for Medical Sciences, allowing industry stakeholders access to the medical school’s analytical, technical and policy expertise.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.
The ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP) has published a new Laboratory Guidance Document (LGD) on Saw Palmetto Extract to help industry stakeholders better identify adulterants.
Utah-based contract manufacturer Capstone Nutrition has been acquired by a private equity firm, showing there is still room for growth in the contract manufacturing sphere despite reports of overcapacity.
The US Food and Drug Administration has shut down a Tennessee dietary supplement manufacturer that allegedly has not complied with repeated orders to not unlawfully distribute unapproved new drugs, adulterated and misbranded dietary supplements and an...